Abiopharma

🔍 Curet Myriam (Executive)

Company: INTUITIVE SURGICAL INC (ISRG)

Report Date: 2026-03-10

Detailed Transactions and Holdings:

• Acquired 105 shares of Common Stock at $229.39 per share (Direct)
  Date: 2026-03-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 105.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 105 shares of Common Stock at $493.95 per share (Direct)
  Date: 2026-03-10 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-10 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 409.00
• Sold 105 shares of Non-Qualified Stock Option (right to buy) at $229.39 per share (Derivative)
  Date: 2026-03-10 | Code: M | Expires: 2030-02-27 | equity_swap_involved: 0 | shares_owned_after: 1,152.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.
• F2: 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.